Issue 2/2023
Content (8 Articles)
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial
Emine Eylem Genç, İrem Sena Saraç, Hayrunnisa Arslan, Ahmet Emre Eşkazan
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
Paulo Nunes Filho, Caroline Albuquerque, Mariana Pilon Capella, Marcio Debiasi
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Shuwen Zheng, Yumei Feng, Chan Li, Jie Zhang, Ke Xie
The Future of Breast Cancer Research in the Survivorship Field
D. Soldato, L. Arecco, E. Agostinetto, M. A. Franzoi, E. Mariamidze, S. Begijanashvili, N. Brunetti, S. Spinaci, C. Solinas, I. Vaz-Luis, A. Di Meglio, M. Lambertini
Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study
Danielle E. Altman, Xinke Zhang, An-Chen Fu, Alissa R. Rams, Jessica A. Baldasaro, Samir Ali Ahmad, Michael Schlichting, Patrick Marquis, Elena Benincasa, Camilo Moulin, Vivek Pawar
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance
Dana Chase, Jessica Perhanidis, Divya Gupta, Linda Kalilani, Amanda Golembesky, Antonio González-Martín
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C. Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D. Cohen